MetLife Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-81,769
| Closed | -$449K | – | 2937 |
|
|
2025
Q1 | $449K | Sell |
81,769
-5,663
| -6% | -$31.1K | ﹤0.01% | 1779 |
|
|
2024
Q4 | $296K | Buy |
87,432
+28,224
| +48% | +$95.7K | ﹤0.01% | 2081 |
|
|
2024
Q3 | $169K | Sell |
59,208
-23,430
| -28% | -$66.8K | ﹤0.01% | 2368 |
|
|
2024
Q2 | $186K | Buy |
82,638
+24,546
| +42% | +$55.2K | ﹤0.01% | 2299 |
|
|
2024
Q1 | $128K | Sell |
58,092
-13,145
| -18% | -$29.1K | ﹤0.01% | 2422 |
|
|
2023
Q4 | $167K | Hold |
71,237
| – | – | ﹤0.01% | 2336 |
|
|
2023
Q3 | $133K | Buy |
+71,237
| New | +$133K | ﹤0.01% | 2438 |
|
|
2023
Q2 | – | Sell |
-71,237
| Closed | -$116K | – | 2996 |
|
|
2023
Q1 | $116K | Buy |
71,237
+45,408
| +176% | +$74K | ﹤0.01% | 2488 |
|
|
2022
Q4 | $34.4K | Sell |
25,829
-45,025
| -64% | -$59.9K | ﹤0.01% | 2788 |
|
|
2022
Q3 | $111K | Hold |
70,854
| – | – | ﹤0.01% | 2634 |
|
|
2022
Q2 | $109K | Buy |
+70,854
| New | +$109K | ﹤0.01% | 2674 |
|
|
2020
Q4 | – | Sell |
-22,612
| Closed | -$134K | – | 2321 |
|
|
2020
Q3 | $134K | Buy |
+22,612
| New | +$134K | ﹤0.01% | 2078 |
|
|
2019
Q4 | – | Sell |
-14,041
| Closed | -$138K | – | 2328 |
|
|
2019
Q3 | $138K | Hold |
14,041
| – | – | ﹤0.01% | 2151 |
|
|
2019
Q2 | $161K | Buy |
+14,041
| New | +$161K | ﹤0.01% | 2157 |
|